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Background: Obesity and gestational diabetes (GDM) in pregnancy are recognized risk factors for adverse outcomes,
including cesarean section (CS), macrosomia and preeclampsia. The aim of this study was to investigate the
independent effect of GDM and obesity on the adverse pregnancy outcomes at term.
Methods: A retrospective cohort of postpartum women, in King Khalid University Hospital, were stratified according to
body mass index (obese ≥30 kg/m2, non-obese <30 kg/m2) and the results of GDM screening into the following
groups, women with no obesity and no GDM (reference group), women with no obesity but with GDM, women
with obesity but no GDM and women with both GDM and obesity. Adverse pregnancy outcomes included high
birth weight, macrosomia, CS delivery and preeclampsia. Multiple logistic regression used to examine independent
associations of GDM and obesity with macrosomia and CS.
Results: 2701 women were included, 44% of them were obese and 15% had GDM. 63% of the women with GDM
were obese. There was significant increase in the percentage of macrosomia, P < 0.001, high birth weight, P < 0.001, CS,
P < 0.001 and preeclampsia, P < 0.001 in women with GDM and obesity compared to the reference group. Obesity
increased the estimated risk of CS delivery, odds ratio (OR) 2.16, confidence intervals (CI) 1.74-2.67. The combination
of GDM and obesity increased the risk of macrosomia OR 3.45, CI 2.05-5.81 and the risk of CS delivery OR 2.26,
CI 1.65-3.11.
Conclusion: Maternal obesity and GDM were independently associated with adverse pregnancy outcomes. The
combination of both conditions further increase the risk.
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Obesity is one of today’s major public health problems
in both developed and developing countries. In 2005
there were around 400 million obese adults; this num-
ber is estimated to reach one billion by the year 2030
[1]. Reports from the Middle East [2] and Saudi Arabia
[3] suggested similar burden of obesity epidemic. The
prevalence of overweight and obesity is higher among
women, with an estimated prevalence of 63% in the re-
productive age group [3] and more than 50% among
pregnant women [4]. Obesity in pregnancy is a recognized
risk factor for many maternal and neonatal adverse
outcomes including increased rate of cesarean section* Correspondence: umlena@yahoo.com
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reproduction in any medium, provided the or(CS), macrosomia, preeclampsia and gestational diabetes
(GDM) [5-7].
The prevalence of GDM in Saudi Arabia is 12%-18%
[8,9] which is one of the highest in the region and the
world. Although there is an international agreement
about the definition of GDM as “carbohydrate intolerance
that begins or is first recognized during pregnancy” [10],
there were many controversies about the adverse effects of
GDM on the pregnancy outcomes and the need for
screening and treatment of women who develop GDM
[11]. However recent reports of randomized controlled
trials and multicenter cohort studies, confirmed the need
for control of hyperglycemia in women with GDM to
improve the pregnancy outcomes [12] and that mater-
nal hyperglycemia at levels even lower than those for
diabetes mellitus (DM) are associated with adverse preg-
nancy outcomes in a linear relationship [13]. GDM isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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as macrosomia and CS delivery [12,14], moreover and
with recent developments in the research on fetal origin
of adult disease, GDM has been linked to long term health
effects on the mothers and their children including; in-
creased risk of developing type 2 diabetes mellitus, mater-
nal and childhood obesity and cardiovascular disease [15].
Few studies explored the relationship between GDM and
maternal obesity and found an increased prevalence of
GDM among obese women compared to those of normal
weight [6], in addition obese women who develop GDM
needed insulin to reach the target blood glucose level
compared to normal weight women who were controlled
by diet alone [16] and that the combination of obesity and
GDM was associated with the worse outcomes compared
to each condition alone [17,18]. A few studies investigated
the independent effect of obesity and maternal hyper-
glycemia on the pregnancy outcome. Ricard et al., who
investigated the independent effects of obesity and GDM
on fetal weight, CS delivery and pregnancy- induced
hypertension, found that obesity had greater independent
effect on these adverse outcomes compared to GDM [18].
In their re- analysis of the HAPO study cohort, the research
group reached a similar conclusion to that of Ricard et al.;
however the greater impact of obesity was not consistent
across all the studied adverse outcomes [17].
The aim of this study was to investigate the independ-
ent effect of GDM and obesity on the pregnancy out-
comes at term in a Saudi population.
Methods
This is a retrospective cohort study, designed to quantify
the independent effects of maternal body mass index (BMI)
and GDM on the pregnancy outcomes. Data were collected
from all consented women who met the inclusion criteria
and delivered in King Khalid University Hospital (KKUH),
for the period of 12 months from the 1st of July 2011 to
30th of June 2012. The inclusion criteria for this study were:
1. Singleton pregnancy
2. Gestational age of ≥ 37 weeks at the time of delivery
3. Availability of documented records of maternal
weight and height at the booking visit.
The exclusion criteria were:
1. Documented history of type 1 or type 2 diabetes
mellitus prior to the index pregnancy.
2. Multiple- pregnancy.
3. Women who were not screened for gestational
diabetes during the index pregnancy.
All women booked for antenatal care at KKUH are
screened for pre-existing diabetes mellitus using fastingblood glucose (FBG) during their first antenatal visit.
Values above 5.3 mmol/l indicate a full oral glucose
tolerance test (OGTT). Further screening is carried
out between 24–28 gestation weeks. Oral glucose
(50 g) was administered, regardless of the time of the
last meal. Venous plasma glucose was measured 1 h later.
A value of 7.8 mmol/l (140 mg/dl) or more indicated the
need for a full diagnostic OGTT. The diagnosis of GDM
is based on the results of a 3-h, 100-g OGTT, interpreted
according to the diagnostic criteria of Carpenter and Cou-
stan [19]. Definitive diagnosis requires that two or more of
the venous plasma glucose concentrations meet or exceed:
fasting, 5.3 mmol/l (95 mg/dl), 1 h 10.0 mmol/l (180 mg/dl),
2 h 8.6 mmol/l (155 mg/dl) and 3 h 7.8 mmol/l (140 mg/dl).
Once diagnosed, women with GDM follow a specific
course of treatment including nutritional therapy and
counseling together with antenatal fetal surveillance.
Insulin therapy is introduced when nutritional therapy
fails to maintain the FBG at 5.8 mmol/l (105 mg /100 ml)
and/or the 2 h postprandial at 7.8 mmol/l (140 mg/dl).
Due to the proven effect of tobacco smoking, includ-
ing environmental tobacco smoke (ETS) exposure, on
the pregnancy outcomes, we collected data on maternal
smoking status. We considered women to be exposed to
ETS when the husband or one of the children smokes at
home. Duration of exposure to ETS was not reported in
this study as only 30% of the participants could recall
the duration of exposure.
The BMI was calculated for each subject using the ma-
ternal weight and height recorded during the booking
visit, according to the following equation; BMI = weight
(kg)/height (m)2. Women were booked for their first
antenatal visit during the first or the second trimester of
pregnancy, subject to availability of appointments. To in-
vestigate the independent effect of maternal obesity and
GDM on the pregnancy outcomes, women were divided
into two groups based on the BMI, non-obese with
BMI < 30 kg/m2 and obese with BMI ≥ 30 kg/m2. Fur-
ther stratification of the study population into a total
of four groups was based on the results of the GDM
screening as follows; women with no GDM and who were
not obese were considered the control group, second
group was women who had GDM but were not obese,
third group was women who were obese but did not have
GDM and the fourth group were women with both obes-
ity and GDM.
Data on the demographic and reproductive characteris-
tics in addition to data on the outcomes of pregnancies
were collected from the participants’ medical records,
after delivery in the post-natal ward, using a pre-designed
data collection sheet. Data on exposure to tobacco smoke
were collected from the participants in the postnatal ward.
The maternal characteristics included in the study were;
maternal age, parity, booking visit weight and height,
Table 1 Maternal and neonatal characteristics of the
studied population
Maternal characteristics
Age (year) 29.38 ± 6.21
Gravidity 3.50 ± 2.65
Parity 2.99 ± 2.18









BMI (kg/m2) 30.25 ± 14.99
Obesity/GDM groups
No GDM No Obesity 1361 (50.4)
GDM No Obesity 155 (5.7)
Obesity No GDM 925 (34.2)
GDM and Obesity 260 (9.6)
ETS exposure
Not exposed 1832 (67.8)
Exposed 869 (32.2)
Neonatal characteristics
Gestational age at delivery (week) 39.11 ± 1.17
Birth weight(kg) 3.19 ± 0.46
Head circumference (cm) 34.44 ± 10.39
Length (cm) 49.74 ± 2.56
Gender (male) 1429 (52.9)
Data expressed as n (%) or mean ± Standard Deviation.
GDM=gestational diabetes mellitus, BMI = body mass index, ETS = environmental
tobacco smoking.
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vaginal or cesarean section (CS), and the occurrence
of GDM or pre-eclampsia (PE) defined as blood pres-
sure ≥140/90 mm Hg after 20 weeks gestation and ≥
0.3 g proteinuria/day [20], during the index pregnancy.
The neonatal characteristics included; gestation age at
delivery, APGAR scores at 5 minutes, birth weight, neo-
natal head circumference, neonatal length and admission
to NICU.
Primary outcomes
Fetal macrosomia (≥4 kg), birth weight, and CS delivery.
Secondary outcomes
Secondary outcomes included; gestation age at delivery
(≥37 weeks), the occurrence of PE during the index preg-
nancy, APGAR scores at 5 minutes, birth weight <2.5 kg,
neonatal head circumference, neonatal length and admis-
sion to NICU.
Statistical analysis
Data were analyzed using Statistical Package for the
Social Sciences (SPSS), Version 17(SPSS Inc., Chicago,
IL, USA). We compared means using Analysis Of Variance
(ANOVA). After assessing normality of distribution of the
variables, either Pearson's chi-square test or Fisher exact
test was used for categorical variables as indicated. P-value
of less than 0.05 considered statistically significant.
Stepwise multivariate logistic regression models were
used to explore the independent associations between
the four groups of combination of maternal obesity and
GDM with adverse pregnancy outcomes, considering
women who were not obese and did not have GDM as the
reference group. Adjusted odd ratios (OR) were calculated.
The following variables were included as confounders for
the final model for macrosomia and CS delivery; maternal
age, parity, ETS exposure and gestation age (≥37 weeks).
Ethical approval
Ethical approval number 11/2862/IRB, was obtained for
this study from institutional review board of the Collage
of Medicine King Saud University before the commence-
ment of the study.
Result
Maternal characteristics and pregnancy outcomes
Of the 3200 women who delivered during the study
period, 2701 met the inclusion criteria and consented to
the study. The mean BMI of the study population at
booking was 30.25 ± 14.99 kg/m2 and 44% of the partici-
pants were obese. The prevalence of GDM was 15%, and
63% of the women who were diagnosed with GDM were
obese (Table 1). Of the study population 869 (32.2%) were
exposed to ETS during the index pregnancy. The meangestation age at booking was 21.8 ± 8.8 weeks; the mean
maternal age was 29.38 ± 6.21 years. More than 50% of the
participants were university graduates or above, however
76.1% of the women in this study were housewives
(Table 1). The characteristics of the neonates in this study
are shown in Table 1.
Univariate analysis showed statistically significant asso-
ciation between maternal obesity and GDM with adverse
pregnancy outcomes (Table 2). There was significantly in-
creased percentage of CS delivery, P <0.001, macrosomia,
P <0.001, PE, P <0.001, increased birth weight P <0.001,
and length of the newborn, P <0.01, for GDM or obesity
alone compared to the reference group. The combination
of GDM and obesity showed considerably higher per-
centages of adverse outcomes compared to either GDM
or obesity alone (Table 2). There was a noticeable trend
Table 2 The effects of Obesity/GDM on the pregnancy outcomes of terms infants
Obesity/GDM groups








Caesarean section 210 (15.4) 27 (17.4) 263 (28.4) 83 (31.9) <0.001
Pre-eclampsia 7 (0.5) 3 (1.9) 14 (1.5) 9 (3.5) <0.001
Gestational age (weeks) 39.15 ± 1.16 38.89 ± 1.00 39.17 ± 1.24 38.86 ± 1.08 <0.001
APGAR score at 5 min 8.91 ± 0.69 8.93 ± 0.57 8.93 ± 0.56 8.92 ± 0.69 0.90
Birth weight (kg) 3.13 ± 0.44 3.17 ± 0.41 3.22 ± 0.45 3.33 ± 0.54 <0.001
Macrosomia ≥4 kg 40 (2.9) 4 (2.6) 47(5.1) 32 (12.3) <0.001
Low birth weight <2500 g 85 (6.2) 8 (5.2) 38 (4.1) 10 (3.8) 0.01
Newborn length (cm) 49.65 ± 2.21 49.29 ± 4.50 49.87 ± 2.70 50.0 ± 2.35 0.01
Newborn head circumference (cm) 34.23 ± 8.87 33.72 ± 3.02 34.89 ± 14.05 34.37 ± 1.46 0.384
NICU admission 61 (4.5) 9 (5.8) 48 (5.2) 15 (5.8) 0.79
NICU = Neonatal Intensive care.
Data is expressed either as number (%) or mean ± standard deviation.
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with obesity alone compared to GDM alone (Table 2).
The combination of GDM and obesity increased the
odds of delivering a macrosomic baby by nearly fourfold,
OR 3.45, Confidence Intervals (CI) (2.05-5.81) (Table 3).
Obesity alone increased the estimated risk of delivering
a macrosomic baby to 1.46, however this risk was not
statistically significant, CI 0.94-2.27, P = 0.092 (Table 3).
The estimated risk of having a CS delivery was in-
creased by more than twofold in obese mothers com-
pared to those who were non-obese and did not develop
GDM, OR 2.16, CI 1.74-2.67, P < 0.001 (Table 3). The
combination of GDM and obesity had similar risk of CS
delivery to that of obesity alone, OR 2.26, CI 1.65-3.11,
P < 0.001 (Table 3).Table 3 Adjusted ORs for macrosomia and cesarean
section delivery in obese and non-obese women with and
without gestational diabetes
Outcome OR CI p-value
Macrosomia
No Obesity No GDM 1.00
No Obesity GDM 0.74 0.26-2.13 0.584
Obesity No GDM 1.46 0.94-2.27 0.092
Obesity GDM 3.45 2.05-5.81 <0.001
Cesarean section delivery
No Obesity No GDM 1.00
No Obesity GDM 0.97 0.62-1.53 0.91
Obesity No GDM 2.16 1.74-2.67 <0.001
Obesity GDM 2.26 1.65-3.11 <0.001
GDM = Gestational Diabetes Mellitus, BMI = Body Mass Index, OR = Odds Ratio.
Reference group: non diabetic non-obese women (BMI <30 kg/m2.
Adjusted for maternal age, parity, gestation age and exposure to
environmental tobacco smoke.Discussion
The results of this study showed that GDM and maternal
obesity were independently associated with adverse preg-
nancy outcomes. The findings confirmed that the combin-
ation of both GDM and obesity had greater impact on
macrosomia and CS delivery than either obesity or GDM
alone. In addition there was a noticeable trend of increment
in maternal and neonatal adverse outcomes in mothers
with obesity alone compared to those with GDM alone.
The greater impact of maternal obesity on the adverse
pregnancy outcomes has been reported by other investiga-
tors [6,21].
While fetal weight is influenced by the parents’ weight
and height through a genetic link, maternal weight has
an additional influence by modulating the intrauterine
environment [22]. Maternal obesity is associated with
hyperinsulinemia, hyperlipidemia and increased inflam-
matory markers levels [23]. The level of circulating mater-
nal lipids near delivery, rather than the maternal glucose
level, was confirmed to be a strong predictor of fetal size
[18,24,25]. This explains our findings of the greater influ-
ence of maternal obesity, both alone and in combination
with GDM, on macrosomia, compared to the influence of
GDM alone.
The high prevalence of 15% for GDM in this study is
consistent with previous reports from Saudi Arabia [8,9]
and is not surprising considering the high prevalence of
obesity among the obstetric population reported in this
study. Our results pointed to modest effect of GDM on
macrosomia compared to maternal obesity, these findings
are consistent with the findings of Ricard et al. [18]. The
pathophysiology of macrosomia in women with GDM is
based on Pedersen hypothesis [26] of maternal hypergly-
cemia leading to fetal hyperinsulinemia and increased
utilization of glucose and hence increased fetal adipose
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finding of high insulin levels in the cord blood of babies
born to diabetic mothers [27]; however good control of
blood glucose did not completely prevent the increase
in macrosomia noticed in women with diabetes [28],
which suggests a role for other mediators that might
share a common pathway with obesity .
In this study we found an independent association be-
tween the frequency of CS delivery and maternal obesity
with twofold increase in the estimated risk for CS delivery
for obese women compared to the reference group. It is
worth mentioning that GDM has not imposed extra risk
for CS delivery over that estimated for maternal obesity.
A recently published systematic review reported an esti-
mated two to threefold increase in the rate of CS for
obese women compared to those with normal weight
[29]. Similar findings were reported by Dietz et al. even
after adjustment for co-morbidity, such as GDM [30].
This finding is relevant considering the increasing rate
of CS delivery [31] and obesity in many of the middle
and high income countries [4,5], taking into account the
significant morbidities in obese women who deliver by
CS such as wound infection, endometritis, urinary tract in-
fection and prolonged postpartum hospitalization [32,33].
The mechanism behind the increased frequency of CS
in obese mother has not been fully explored, however
cephalopelvic disproportion due to macrosomia and nar-
row maternal pelvis due to increased soft tissue mass [34],
slow labour progression [35] and increased frequencies of
emergencies [36] were all proposed as explanations for the
association of maternal obesity and CS delivery.
The prevalence of maternal obesity in this study was
44% which is higher than that reported for Saudi obstet-
rics population but similar to at risk population of over
weight and obese mothers from the same report [4].
Marked increase in the prevalence of maternal obesity in
the last decade was reported from other developed coun-
tries and the region [6,37]. Our findings indicated that
most of the study population received formal education
and more than 50% of the participants were university
graduates; however more than 75% of the participants did
not work for pay which might indicate the predominance
of sedentary life style in this cohort, considering the high
standard of living in Saudi Arabia (Gross national income
per capita is $30,160) [38] and the availability of household
help for domestic work.
Few reports investigated interventions to improve the
outcomes in pregnancies complicated by maternal obesity.
Recently published systematic reviews have shown that
dietary interventions during pregnancy are effective in the
prevention of maternal obesity and its adverse effects on
the mother and the newborn [39,40].
Based on the results of this study and previous similar
reports [18,25], we believe it is prudent for maternityhealth services worldwide to implement evidence based
intervention for reducing and preventing obesity in preg-
nancy and its adverse effects on the mother and the fetus.
Greater efforts should be directed towards investigating
effective interventions for reducing maternal weight be-
fore pregnancy, such as bariatric surgery. It is important
that women in the reproductive age group are aware of
the adverse consequence of obesity on the pregnancy
outcomes which will motivate better utilization of effective
interventions.
We are aware of the limitations of this study including
the retrospective nature of the investigation and the lack
of data on pre-pregnancy maternal weight due to the
routine late booking for antenatal care in the hospital,
considering that maternal adiposity, which was the pro-
posed influence of adverse pregnancy outcomes in this
study, correlates better with maternal pre-pregnancy and
first trimester weight rather than maternal weight in late
pregnancy [41]. However other measurements of maternal
obesity such as gestational weight gain, central obesity and
modified categories of BMI to define obesity during preg-
nancy, were found to be associated with macrosomia and
increased risk of CS [17,42,43]. This limitation of the
study might have attenuated the effects of obesity in out-
comes other than macrosomia and CS because of the vari-
ation in maternal weight gain during pregnancy; however
it would not produce false positive results. The prevalence
of obesity in this study is higher than previously reported,
which might be due to the late booking of the women for
antenatal care during the second trimester, this might
limit the generalization of the results to the whole preg-
nant population of the Kingdom.
Conclusion
Maternal obesity and GDM were independently associated
with adverse pregnancy outcomes. The combination of
both conditions further increase the risk of adverse preg-
nancy outcomes at term.
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